Episode Details
Join us on the latest episode! Our Guest: James Foster, CEO of Virax Biolabs
What you’ll get out of this episode:
- Learn about James Foster’s transition from investment banking to founding Virax Biolabs.
- Discover Virax’s evolution from consumer goods to biotech and its growth during COVID.
- Gain insights into the T cell platform Virax Immune, including development and launch plans.
- Understand Virax’s three key advantages over competitors, including an integrated solution.
- Explore the company’s adaptability to viral threats and goal to become indispensable.
- Grasp how Virax focuses on preventative medicine, global reach, and a shift in viral diagnosis.
Watch
Listen
Read
Introduction
In a recent podcast, Jared S. Taylor had an engaging conversation with James Foster, the CEO of Virax Biolabs, a company focused on innovative diagnosis and detection of immune responses to viral diseases. Here’s a comprehensive transcription of the interview, including insights into Virax’s proprietary T cell platform called Virax Immune.
About James Foster and Virax Biolabs
- Background of James Foster: Starting off in investment banking in London, James Foster co-founded Virax (known as Virax Biolabs) in 2013. He shares his journey from investment banking during the financial crisis to entrepreneurship, culminating in listing the company on NASDAQ under the ticker VRAX.
- From Inception to Success: Virax Biolabs started with distributing fast-moving consumer goods and later moved into biotech and in vitro diagnostics. The COVID pandemic acted as a catalyst, attracting interest from investment banks and propelling the company’s growth.
Virax Immune Platform
- Launch: Since 2020, Virax has been developing its T cell platform, Virax Immune. Entering its full clinical trial program in summer, Virax plans to launch the product in Europe in Q3 and possibly in the US with FDA approval soon after.
- Unique Features and Advantages: The Virax Immune platform has three significant advantages compared to competitors like Oxford Immunotech and Adaptive Biotech.
- Integrated Solution: Virax Immune offers an integrated solution, including blood testing results and health recommendations via a proprietary mobile application.
- Preventative Medicine Approach: The platform aims to guide individuals by providing an immune passport, unique in determining immune resistance to acetoviruses.
- Affordable and Lab Agnostic: The diagnostic is designed to be lab agnostic and priced affordably to appeal to both developed and developing markets.
The Future Vision of Virax Biolabs
- Adaptability and Expansion: James Foster emphasizes the simplicity and adaptability of the proprietary tech that will enable Virax to be at the forefront of any new viral threat. The company aims to expand its reach into other viruses and become indispensable to the scientific and clinical community.
- Role in Controlling Viral Infections: With T cell-mediated immunity playing a central role in controlling viral infections, Virax intends to be at the forefront by adapting its immune technology to overcome future challenges.
Slice of Wrap Up
Jared S. Taylor’s interview with James Foster provides an intriguing look into Virax Biolabs’ technology, competition, and vision. With innovative approaches like the Virax Immune platform, Virax shows promise in shifting the paradigm of viral diagnosis and immune response detection. Stay tuned for updates on their inspiring journey.
WORD FROM OUR SPONSORS:
Our sponsors for this episode are Sage Growth Partners, FlipMD by GoodRX and Quantum Health
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners
GoodRx is a company that operates a platform and mobile application providing information and discounts on prescription drugs. It was founded in 2011 with the aim of helping consumers save money on their medication costs. GoodRx acts as a bridge between consumers, pharmacies, and pharmaceutical companies.
The primary function of GoodRx is to aggregate and compare prices of prescription drugs from various pharmacies across the United States. They gather pricing information for both generic and brand-name medications, allowing users to find the most affordable options available to them. The platform provides users with details about drug prices, discounts, and savings opportunities at different pharmacies in their local area.
For more information, please go to https://www.goodrx.com/ & follow FlipMD on social media – @goodrx
Quantum Health is an award-winning consumer healthcare navigation company that delivers an unparalleled consumer experience based on empathy and trust, enabling employers to achieve industry-leading satisfaction rates and independently validated claim savings. Launched in 1999, Quantum Health’s model is based on years of consumer research and the insights learned from guiding millions of consumers and their providers through their healthcare journey. Visit: https://quantum-health.com/ and follow Quantum health on social media – @Quantum Health
To learn more about Virax Biolabs please use the links below:
– Virax Biolabs LinkedIn – Virax Biolabs Website –
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – LinkedIn – Twitter – YouTube – Newsletter –
